Tag : phase

Latest News

Poxel Presents Imeglimin Phase 3 TIMES Results and PXL770 Preclinical Cardio-Renal Results at the 56th European Association for the Study of Diabetes Annual Meeting

Newsemia
LYON, France–(BUSINESS WIRE)–POXEL SA (Euronext – POXEL – FR0012432516), a biopharmaceutical company focused on the development of innovative treatments for metabolic disorders, including type 2...
Gastroenterology

Study: R-spondin growth factor reduces intestinal tumors in early phase of colorectal cancer

Newsemia
Colorectal cancer constitute the third most common cancer in the Western world. Their incidence constantly increases as the population ages, and despite recent advances in...
Cardiology

Factors associated with in-hospital mortality and adverse outcomes during the vulnerable post-discharge phase after the first episode of acute heart failure: results of the NOVICA-2 study.

Newsemia
Related Articles Factors associated with in-hospital mortality and adverse outcomes during the vulnerable post-discharge phase after the first episode of acute heart failure: results of...
Gastroenterology

Chemoradiotherapy with extended nodal irradiation and/or erlotinib in locally advanced oesophageal squamous cell cancer: long-term update of a randomised phase 3 trial

Newsemia
Chemoradiotherapy with extended nodal irradiation and/or erlotinib in locally advanced oesophageal squamous cell cancer: long-term update of a randomised phase 3 trial Source link...
Pharma / Biotech

Phase 1 dose escalation trial of volasertib in combination with decitabine in patients with acute myeloid leukemia.

Newsemia
Phase 1 dose escalation trial of volasertib in combination with decitabine in patients with acute myeloid leukemia. Int J Hematol. 2020 Sep 20;: Authors: Cortes...
Latest News

Algiax Pharmaceuticals Announces First Patient Enrolled in Phase IIa Multi-center Proof-of-Concept Study Evaluating AP-325 in Chronic Neuropathic Pain

Newsemia
DÜSSELDORF, Germany–(BUSINESS WIRE)– #chronic–Algiax Pharmaceuticals Announces First Patient Enrolled in Phase IIa Multi-center Proof-of-Concept Study Evaluating AP-325 in Chronic Neuropathic Pain Source link...
Latest News

Roche drug that previously failed in Covid-19 pneumonia shows efficacy in Phase III study

Newsemia
Actemra reduced the percentage of patients with Covid-19 pneumonia who progressed to requiring mechanical ventilation, but did not show an improvement in mortality, time to...
Latest News

LYNPARZA Reduced Risk of Death by 31% vs. Enzalutamide or Abiraterone for Men with BRCA1/2 or ATM-Mutated Metastatic Castration Resistant Prostate Cancer Who Progressed Following Enzalutamide or Abiraterone in Phase 3 PROfound Trial

Newsemia
KENILWORTH, N.J.–(BUSINESS WIRE)—- $MRK #MRK–LYNPARZA Reduced Risk of Death by 31% for Men with BRCA1/2 or ATM-Mutated mCRPC Who Progressed Following Enzalutamide or Abiraterone in...
Latest News

LYNPARZA® (olaparib) Reduced the Risk of Death by 31% in BRCA1/2 or ATM-mutated Metastatic Castration-Resistant Prostate Cancer in Phase III Profound Trial

Newsemia
WILMINGTON, Del.–(BUSINESS WIRE)–AstraZeneca and Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced final results from the Phase III PROfound...
Latest News

Opdivo® (nivolumab) in Combination with CABOMETYX® (cabozantinib) Demonstrates Significant Survival Benefits in Patients with Advanced Renal Cell Carcinoma in Pivotal Phase 3 CheckMate -9ER Trial

Newsemia
PRINCETON, N.J., & ALAMEDA, Calif.–(BUSINESS WIRE)—- $BMY #BMS–Opdivo in Combination with CABOMETYX Demonstrates Significant Survival Benefits in Patients with Advanced Renal Cell Carcinoma…. Source link...
Latest News

ESMO 2020: Cabometyx® (cabozantinib) in Combination With Opdivo® (nivolumab) Demonstrates Significant Survival Benefits in Patients With Advanced Renal Cell Carcinoma in Pivotal Phase III CheckMate -9ER Trial

Newsemia
PARIS–(BUSINESS WIRE)–Regulatory News: Ipsen (Euronext: IPN; ADR: IPSEY) today announced the first presentation of results from the pivotal Phase III CheckMate -9ER trial, in which...
Latest News

ESMO 2020 : Cabometyx® (cabozantinib) en association avec Opdivo® (nivolumab) démontre des bénéfices significatifs en termes de survie chez les patients atteints d’un carcinome du rein avancé dans l’étude pivotale de Phase III CheckMate 9ER

Newsemia
PARIS–(BUSINESS WIRE)–Regulatory News: Ipsen (Euronext : IPN ; ADR : IPSEY) a annoncé aujourd’hui la première présentation des résultats de l’étude pivotale de Phase III...
Cardiology

The clinical impact of phase offset errors and different correction methods in cardiovascular magnetic resonance phase contrast imaging: a multi-scanner study.

Newsemia
Related Articles The clinical impact of phase offset errors and different correction methods in cardiovascular magnetic resonance phase contrast imaging: a multi-scanner study. J Cardiovasc...
Latest News

Incyte annonce les résultats encourageants de l’essai de Phase 2 sur le retifanlimab (INCMGA0012) chez des patients atteints d’un carcinome épidermoïde avancé du canal anal déjà traités

Newsemia
WILMINGTON, Delaware–(BUSINESS WIRE)–Incyte (Nasdaq:INCY) a annoncé aujourd’hui les résultats de son essai de Phase 2 POD1UM-202 qui évalue le retifanlimab, un inhibiteur de PD-1, chez...
AI/ML

Development of a volumetric pancreas segmentation CT dataset for AI applications through trained technologists: a study during the COVID 19 containment phase.

Newsemia
Related Articles Development of a volumetric pancreas segmentation CT dataset for AI applications through trained technologists: a study during the COVID 19 containment phase. Abdom...

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy

COVID-19

COVID-19 (Coronavirus) is a new illness that is having a major effect on all businesses globally LIVE COVID-19 STATISTICS FOR World